Pharma Cent Mongolia LLC
Using modern technology that meets international standards.
Popular Products
New Project
DIABELUS semaglutide
Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Jane Oliver
Let's take a look at the various comments from customers about us
A cost-effective choice
Pharma Cent’s drugs comply with Chinese GMP standards, with quality comparable to imported drugs and prices 20% -25% lower, significantly reducing patients’ medication burden and improving treatment compliance.
Jasper
Benchmark for Import Substitution
To achieve an annual import substitution of 15.1 million US dollars, filling Mongolia’s pharmaceutical production capacity gap that meets international standards, and promoting the independent and controllable development of the local pharmaceutical industry.
Solange
Guardian of People's Livelihood and Health
Solving the dilemma of people reducing drug prices due to high import prices, drugs targeting common diseases are safe and effective, and are a reliable force in safeguarding people’s health.
Theodore
we aim to replace imports, treat common diseases with high quality and service, and produce rare pharmaceutical products, improving the health of the people, and meeting consumer needs.
In addition, it has a significant impact on the development of Mongolia's healthcare sector, especially the pharmaceutical industry. While 70 million USD worth of tablets are imported annually, we have the opportunity to produce 15.1 million USD worth of products that can replace imports domestically.
People's Well-being
Producing 75 million units of 12 drug types under China GMP standards, priced 20-25% lower than market alternatives. High-cost-performance imports replacement reduces public medication burden.
Import Substitution
15.1millionannualimportsubstitution,cuttingforeignexchangeoutflow,easingMongolia ′ s70 million annual tablet import reliance, and enhancing industrial autonomy.
Industrial Empowerment
Filling the gap in Mongolia's modern pharmaceutical production capacity meeting international standards, driving local medical technology and management upgrades, and promoting industrial chain collaboration.